 | Up a level |
Journal Article
Awasthi, Rakesh, Pacaud, Lida, Waldron, Edward, Tam, Constantine S., Jager, Ulrich, Borchmann, Peter, Jaglowski, Samantha 
ORCID: 0000-0002-4335-2554, Foley, Stephen Ronan, van Besien, Koen ORCID: 0000-0002-8164-6211, Wagner-Johnston, Nina D., Kersten, Marie Jose, Schuster, Stephen J., Salles, Gilles, Maziarz, Richard T., Anak, Ozlem, del Corral, Christopher, Chu, Jufen, Gershgorin, Irina, Pruteanu-Malinici, Iulian, Chakraborty, Abhijit, Mueller, Karen Thudium and Waller, Edmund K.
(2020).
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
Blood Adv., 4 (3).
S. 560 - 573.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 2473-9537
Schuster, Stephen J., Bishop, Michael R., Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, Waller, Edmund K., Holte, Harald, McGuirk, Joseph P., Jaglowski, Samantha, Tobinai, Kensei, Andreadis, Charalambos, Fleury, Isabelle, Mielke, Stephan, Teshima, Takanori, Westin, Jason R., Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Magenau, John M., Wagner-Johnston, Nina D., Kato, Koji, Kersten, Marie Jose, Van Besien, Koen, Chu, Jufen, Jary, Aline, Anak, Ozlem, Salles, Gilles and Maziarz, Richard Thomas T. (2018). Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020